Ok so on page 12-13 it describes that COVID has delayed all clinical trials and that full secondary data collection hasnt completed for the trial yet which means the NOVARTIS deal hasnt closed yet. This may mean an extension to the agreed mid March closing date of the deal? also details the deal is $25m cash and $25m equity?
Ann: Half Year Report and Accounts (including Appendix 4D), page-33
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.15 |
Change
0.010(0.32%) |
Mkt cap ! $3.989B | |||
| Open | High | Low | Value | Volume |
| $3.20 | $3.23 | $3.13 | $6.250M | 1.964M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 65952 | $3.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.15 | 18727 | 6 |
View Market Depth
| Last trade - 10.49am 04/02/2025 (20 minute delay) ? |
| MSB (ASX) Chart |